From: Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
Stage(i)
α i
ω i
δ i
e i
1
0.5
0.95
1.000
73
2
0.25
0.923
140
3
0.1
0.884
217
4
0.025
0.9
0.843
262